2Kirkpatrick T, Coekshott ID, Douglas EJ, et al. Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth, 1988,60 : 146-150.
3Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology, 2000,92 : 727-738.
4Kataria BK, Ved SA, Nicodemus HF, et al. The pharmacokinetics of propofol in children using three different data analysis approaches. Anesthesiology, 1994, 80:104-122.
5Murat I, Billard V, Vernois J, et al. Pharmacokinetics of propofol after a single dose in childern aged 1-3 years with minor burns. Anesthesiology, 1996,84 : 26-32.
6Gin T, Gregory MA, Chan K, et al. Pharmacokinetics of propofol in women undergoing elective caesarean section. Br J Anaesth,1990,64: 148-153.
7Kanto J,Gepts E. Pharmacokinetics implications for the clinical use of propofol. Clin Pharmacokinet, 1989,17:308-326.
8Yanovski SZ, Reynolds JS, Boyle AJ, et al. Resting metabolic rate in African-American and Caucasian girls.Obes Res, 1997,5 : 321-325.
9Bailey JM, Mora CT, Sharer SL. Pharmacokinetics of propofol in adult patients undergoing coronary revascularization. Anesthesiology, 1996,84 : 1288-1297.
10Teh J, Short TG, Wong J, et al. Pharmacokinetic interactions between midazolam and propofol: an infusion study. Br J Anaesth, 1994,72 : 62-65.
